Company intelligence / Profile preview

PolyVascular

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

PolyVascular’s polymer-based, transcatheter pulmonary valve has demonstrated durability and scalability, with the goal to enter first-in-human trials within the next two years. The technology has secured both NIH SBIR funding and major pediatric innovation grants but has not yet reported results from human clinical studies.

Therapeutic areas: Cardiovascular
Modalities: DevicePolymer-based implant
Industry: Implantable Medical Devices

Partnerships

CobiCure Medical Technologies (strategic grant/support partner)Baylis Medical Technologies (Board observer involvement, not formal partnership)

Beyond the preview

Go deeper on PolyVascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PolyVascular.

Explore the full profile